Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Apr;15(2):109-15.
doi: 10.1111/j.1750-3639.2005.tb00505.x.

Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 cases

Affiliations
Comparative Study

Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 cases

Arie Perry et al. Brain Pathol. 2005 Apr.

Abstract

Meningothelial hyperplasia is a poorly characterized entity, often associated with advanced age, chronic renal failure, trauma, hemorrhage, and neoplasia. In order to elucidate the nature of this lesion, 11 cases defined by the presence of nests of 10 or more cell layers thick, were compared with normal arachnoidal cap cells and meningiomas. Immunohistochemistry and FISH were performed to determine NF2 (merlin), protein 4.1B, EMA, progesterone receptor (PR), EGFR, survivin, VEGF, PDGF-BB, PDGFR-beta, E-cadherin, and cathepsin D status. All cases had at least one putative predisposing factor, including hemorrhage (7), chronic renal disease (5), old age (5), trauma (1), and an adjacent optic nerve pilocytic astrocytoma (1). There was typically a discontinuous growth pattern, with no invasion of surrounding normal tissue. No gene deletions were found, though scattered polyploid cells were seen in 2 cases. The immunoprofile was similar to normal cap cells with one exception; whereas normal cells were uniformly negative for PR, nuclear positivity was seen in 64% of hyperplasias, a frequency similar to that of benign meningiomas. Our data suggest that meningothelial hyperplasia is a reactive process that is usually distinguishable from meningioma based on clinicopathologic and genetic features. It may be preneoplastic in some, though further studies are needed to test this hypothesis.

PubMed Disclaimer

References

    1. Artlich A, Schmidt D (1990) Immunohistochemical profile of meningiomas and their histological subtypes. Hum Pathol 21:843–49. - PubMed
    1. Bajenaru ML, Garbow JR, Perry A, Hernandez MR, Gutmann DH. Natural history of neurofibromatosis 1‐associated optic nerve glioma formation in mice. Ann Neurol in press. - PubMed
    1. Bellur SN, Chandra V, McDonald (1980) Arachnoidal cell hyperplasia. Its relationship to aging and chronic renal failure. Arch Pathol Lab Med 104:414–416. - PubMed
    1. Carroll RS, Black PM, Zhang J, Kirsch M, Percec I, Lau N, Guha A (1997) Expression and activation of epidermal growth factor receptors in meningiomas. J Neurosurg 87:315–323. - PubMed
    1. Castilla EA, Prayson RA, Abramovich CM, Cohen ML (2003) Immunohistochemical expression of cathepsin D in meningiomas. Am J Clin Pathol 119:123–128. - PubMed

Publication types